South Africa approves AstraZeneca vaccine for emergency use
South Africa has approved AstraZeneca's COVID-19 vaccine for emergency use and is reviewing applications by rival manufacturers, Johnson & Johnson and Pfizer, the medicines regulator said on Wednesday.
"In terms of the AstraZeneca vaccine … this has been granted emergency use (approval) and there will be a press conference with the minister of health on this (later)," said Helen Rees, chairwoman of the South African Health Products board, during a media briefing.
ALSO READ
-
AfDB selects four green hydrogen projects of $20 million grants in Africa
-
Following Money: South Africa’s Trade Gaps Point to Possible Illicit Flows
-
Chilling Discovery Near Johannesburg: Ninth Woman's Body Unveiled
-
Global Health Updates: ByteDance AI Spin-off, Cancer Drug Expansion, and Vaccine Challenges
Google News